(Q34567916)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16990857%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

review article

1 reference

title

Mechanisms of cutaneous toxicities to EGFR inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16990857%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16990857%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

author name string

Mario E Lacouture

series ordinal

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16990857%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

published in

Nature Reviews Cancer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16990857%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16990857%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16990857%20AND%20SRC:MED&resulttype=core&format=json

30 December 2019

page(s)

803-812

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16990857%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrc1970

30 December 2019

exact match

0 references

cites work

Blockade of the EGF receptor induces a deranged chemokine expression in keratinocytes leading to enhanced skin inflammation

1 reference

Matrix-independent survival of human keratinocytes through an EGF receptor/MAPK-kinase-dependent pathway

21 January 2018

1 reference

ERBB receptors and cancer: the complexity of targeted inhibitors

21 January 2018

1 reference

Issues and progress with protein kinase inhibitors for cancer treatment

31 March 2020

1 reference

31 March 2020

Cetuximab-induced acne

1 reference

Cutaneous adverse effects with HER1/EGFR-targeted agents: is there a silver lining?

31 March 2020

1 reference

Cutaneous side-effects of kinase inhibitors and blocking antibodies

31 March 2020

1 reference

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

31 March 2020

1 reference

Getting under the skin of epidermal morphogenesis

31 March 2020

1 reference

The cornified envelope: a model of cell death in the skin

31 March 2020

1 reference

Immunolocalization of Epidermal Growth Factor Receptors in Normal Developing Human Skin

31 March 2020

1 reference

Epithelial immaturity and multiorgan failure in mice lacking epidermal growth factor receptor

31 March 2020

1 reference

EGF upregulates, whereas TGF-beta downregulates, the hyaluronan synthases Has2 and Has3 in organotypic keratinocyte cultures: correlations with epidermal proliferation and differentiation

31 March 2020

1 reference

EGF-receptor tyrosine kinase inhibition induces keratinocyte growth arrest and terminal differentiation

31 March 2020

1 reference

Endogenous EGF-family growth factors are necessary for the progression from the G1 to S phase in human keratinocytes

31 March 2020

1 reference

EGF receptor signaling inhibits keratinocyte apoptosis: evidence for mediation by Bcl-XL

31 March 2020

1 reference

Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment

31 March 2020

1 reference

New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers

31 March 2020

1 reference

Apoptosis signal-regulating kinase 1 (ASK1) is an intracellular inducer of keratinocyte differentiation

31 March 2020

1 reference

Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype

31 March 2020

1 reference

Stats: transcriptional control and biological impact

31 March 2020

1 reference

Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells

31 March 2020

1 reference

ERK1/2 regulates epidermal chemokine expression and skin inflammation

31 March 2020

1 reference

Molecular determinants of cetuximab efficacy

31 March 2020

1 reference

Antitumor activity of erlotinib (OSI-774, Tarceva) alone or in combination in human non-small cell lung cancer tumor xenograft models

31 March 2020

1 reference

Randomized phase III trial results of panitumumab, a fully human anti-epidermal growth factor receptor monoclonal antibody, in metastatic colorectal cancer

31 March 2020

1 reference

Molecular basis of sun-induced premature skin ageing and retinoid antagonism.

31 March 2020

1 reference

Ultraviolet irradiation induces keratinocyte proliferation and epidermal hyperplasia through the activation of the epidermal growth factor receptor

31 March 2020

1 reference

Keratinocyte apoptosis induced by ultraviolet B radiation and CD95 ligation -- differential protection through epidermal growth factor receptor activation and Bcl-x(L) expression

31 March 2020

1 reference

Acneiform eruption induced by epidermal growth factor receptor inhibitors in patients with solid tumours.

31 March 2020

1 reference

Mechanisms of disease: Radiosensitization by epidermal growth factor receptor inhibitors

31 March 2020

1 reference

Erlotinib induced skin rash spares skin in previous radiotherapy field.

31 March 2020

1 reference

Radiation dermatitis: clinical presentation, pathophysiology, and treatment 2006.

31 March 2020

1 reference

Untangling the ErbB signalling network

31 March 2020

1 reference

Selective oral epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 is generally well-tolerated and has activity in non-small-cell lung cancer and other solid tumors: results of a phase I trial

31 March 2020

1 reference

Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types.

31 March 2020

1 reference

Evaluation of biologic end points and pharmacokinetics in patients with metastatic breast cancer after treatment with erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor

31 March 2020

1 reference

Reversible G(1) arrest induced by inhibition of the epidermal growth factor receptor tyrosine kinase requires up-regulation of p27(KIP1) independent of MAPK activity

31 March 2020

1 reference

Activation of epidermal growth factor receptor promotes late terminal differentiation of cell-matrix interaction-disrupted keratinocytes

31 March 2020

1 reference

Stat3 links activated keratinocytes and immunocytes required for development of psoriasis in a novel transgenic mouse model

31 March 2020

1 reference

Graft-versus-host disease of the skin: life and death on the epidermal edge.

31 March 2020

1 reference

Toxic epidermal necrolysis: current evidence, practical management and future directions

31 March 2020

1 reference

Follicular and epidermal alterations in patients treated with ZD1839 (Iressa), an inhibitor of the epidermal growth factor receptor

31 March 2020

1 reference

Cutaneous side-effects in cancer patients treated with the antiepidermal growth factor receptor antibody C225

31 March 2020

1 reference

Severe cutaneous toxicity following treatment with gefitinib (ZD1839).

31 March 2020

1 reference

Purpuric drug eruption possibly due to gefinitib (Iressa).

31 March 2020

1 reference

Complications of therapy in cancer patients: Case 1. Paronychia and skin hyperpigmentation induced by gefitinib in advanced non-small-cell lung cancer

31 March 2020

1 reference

Acneiform lesions secondary to ZD1839, an inhibitor of the epidermal growth factor receptor.

31 March 2020

1 reference

Immunohistochemical localization of transforming growth factor-alpha and epithelial growth factor receptor in human fetal developing skin, psoriasis and restrictive dermopathy

31 March 2020

1 reference

Maintenance of human skin in organ culture: role for insulin-like growth factor-1 receptor and epidermal growth factor receptor

31 March 2020

1 reference

Effects of EGF on the morphology and patterns of DNA synthesis in isolated human hair follicles

31 March 2020

1 reference

Nonscarring inflammatory alopecia associated with the epidermal growth factor receptor inhibitor gefitinib

31 March 2020

1 reference

Epidermal growth factor as a biologic switch in hair growth cycle

31 March 2020

1 reference

Immune Privilege in Hair Growth

31 March 2020

1 reference

Paronychia Induced by Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor

31 March 2020

1 reference

Development of multiple paronychia and periungual granulation in patients treated with gefitinib, an inhibitor of epidermal growth factor receptor.

31 March 2020

1 reference

Etretinate and the nails (study of 130 cases) possible mechanisms of some side-effects

31 March 2020

1 reference

Management of rash and other toxicities in patients treated with epidermal growth factor receptor-targeted agents.

31 March 2020

1 reference

HER1/EGFR inhibitor-associated rash: future directions for management and investigation outcomes from the HER1/EGFR inhibitor rash management forum

31 March 2020

1 reference

Effects of FK506-binding protein 12 and FK506 on autophosphorylation of epidermal growth factor receptor

31 March 2020

1 reference

Successful treatment with oral isotretinoin of acneiform skin lesions associated with cetuximab therapy

31 March 2020

1 reference

Clinical signs, pathophysiology and management of skin toxicity during therapy with epidermal growth factor receptor inhibitors

31 March 2020

1 reference

Tetracyclines: nonantibiotic properties and their clinical implications

31 March 2020

1 reference

Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells

31 March 2020

1 reference

Epidermal growth factor receptor dimerization status determines skin toxicity to HER-kinase targeted therapies

31 March 2020

1 reference

Phase I and pharmacologic study of OSI-774, an epidermal growth factor receptor tyrosine kinase inhibitor, in patients with advanced solid malignancies

31 March 2020

1 reference